Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Meta-analysis of 1,096 patients from 11 randomized controlled trials

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 1, 2013, Pages 515-521

  Liang, Zhong Guo ^a   Zhu, Xiao Dong ^a   Tan, Ai Hua ^a   Jiang, Yan Ming ^a   Qu, Song ^a   Su, Fang ^a   Xu, Guo Zeng ^a  

^a Guangxi Cancer Institute   (China)

Author keywords

Adjuvant chemotherapy; Chemoradiotherapy; Induction chemotherapy; Nasopharyngeal carcinoma

Indexed keywords

EID: 84877121479     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.1.515     Document Type: Article

References (26)

1. Al-Sarraf M, LeBlanc M, Giri PG, et al (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol, 16, 1310-7.
2. Chan AT, Teo PM,Johnson PJ (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007-15.
3. Chan AT, Hui E, Ma B, et al (2005). A randomized phase II study of concurrent cisplatin-radiotherapy (RT) with or without neoadjuvant chemotherapy using docetaxel (Taxotere) and cisplatin in advanced nasopharyngeal carcinoma (NPC). 41st Annual Meeting of the American Society of Clinical Oncology (ASCO), J Clin Oncol, Abstract No. 5544.
4. Chen XJ, Qiu RL, Yang CL, Liu YQ (2012). Study of TPF neoadjuvant chemotherapy followed by concurrent intensity modulated radiochemotherapy in the treatment for 30 cases with locally advanced nasopharyngeal carcinoma. Chin J Clin Oncol Rehabil, 19, 201-4.
5. Cui JD, Long GN, Zhang Y, et al (2012). Study of TPF neoadjuvant chemotherapy followed by concurrent intensity modulated radiochemotherapy in the treatment for 30 cases with locally advanced nasopharyngeal carcinoma. Chin Clin Oncol, 17, 524-9.
6. Fong KW, Chua EJ, Chua ET, et al (1996). Patient profile and survival in 270 computer tomography-staged patients with nasopharyngeal cancer treated at the Singapore General Hospital. Ann Acad Med Singapore, 25, 341-6.
7. Fountzilas G, Ciuleanu E, Kalogera-Fountzila A, et al (2009). Induction chemotherapy (IC) followed by concomitant chemoradiotherapy (CCRT) versus CCRT alone in patients with locally advanced nasopharyngeal carcinoma (LA-NPC) - A randomized phase II study of the Hellenic Cooperative Oncology Group. Eur J Cancer, 7, 471.
8. Fountzilas G, Ciuleanu E, Bobos M, et al (2012). Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: A randomized phase II study conducted by the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation. Ann Oncol, 23, 427-35.
9. Hareyama M, Sakata K, Shirato H, et al (2002). A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer, 94, 2217-23.
10. He AJ (2011). Neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Hebei Med J, 33, 2115-6.
11. He QD, Yang L, Nie YH,Kang HB (2009). A phase ¢ò study of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma. Chin Clin Oncol, 14, 1011-4.
12. Heng DM, Wee J, Fong KW, et al (1999). Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer, 86, 1912-20.
13. Julian PTH and Sally G (2011). Cochrane handbook for systematic review of interventions version 5.0.1[updated March 2011].The cochrane collaboration 2011,available from www.cochranehandbook.org.
14. Huang S, Deng G, Huang G, et al (2012). Efficacy of induction chemotherapy combined with concurrent chemoradiotherapy for advanced nasopharyngeal carcinoma. Chin J Clin Oncol, 39, 788-91.
15. Hui EP, Ma BB, Leung SF, et al (2009). Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. J Clin Oncol, 27, 242-9.
16. Ma HM, Yuan X, Huang YL, Lin YF, Liu CX (2009). Paclitaxel and cisplatin, 5-fluorouracil (TPF) programme neoadjuvant chemotherapy for advanced nasopharyngeal carcinoma. Mod Oncol, 17, 1233-5.
17. Ruste SA, Dizon DS, Ramirez F, et al (2011). Induction chemotherapy followed by concurrent chemoradiotherapy vs concurrent chemoradiotherapy followed by chemotherapy in the treatment of patients with advanced nasopharyngeal carcinoma. Phil J Intern Med, 49, 1-7.
18. Sun R (2009). Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma [master].
19. Teo P, Yu P, Lee WY, et al (1996). Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys, 36, 291-304.
20. Wang XJ, Shou T, Diao XM, et al (2011). Neoadjuvant chemotherapy with vinorelbine followed by concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma. J Pract Med, 27, 4451-3.
21. Xu MJ, Ye JM, Wu LQ,Wang XC (2011). Study of TPF neoadjuvant chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced nasopharyngeal carcinoma. J Pract Oncol, 26, 291-4.
22. Yamazaki T, Ishiki H, Okano S, et al (2011). Impact of induction chemotherapy on local control for locally advanced nasopharyngeal cancer. Eur J Cancer, 47, S569.
23. Yu H-S, Wang X, Song AQ, et al (2012). Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma. Asian Pacific J Cancer Prev, 13, 3961-5.
24. Zeng XT, Leng WD, Li S, Guo Y, Wang P (2011). How to understand and use GRADE system correctly? A brief outline. Chin J Evid-Based Med, 11, 985-90.
25. Zhang L, Zhao C, Ghimire B, et al (2010). The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer, 10, 558.
26. Zhong WH, Feng HX, Jiang HH, Zhang LP (2011). Clinical observation and nursing of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy with or without adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Chin Med Innov, 20, 162-4